Text and Data Mining valid from 2018-06-15
First Online: 15 June 2018
Compliance with Ethical Standards
: No funding was received for the preparation of this article.
: Pam R. Taub has disclosed a potential conflict of interest as she has received a grant from Amgen to investigate the effect of Ivabradine in patients with POTS. Adena Zadourian, Taylor A. Doherty, and Iwona Swiatkiewicz have no conflicts of interest to disclose. This manuscript was prepared in Compliance with Ethical Standards.